Answers are grounded in this paper and cite their sources.
Aims and Backgrounds: Facial aging is a multifactorial process involving cellular senescence, ultraviolet damage, and structural decline across the epidermis, dermis, subcutaneous fat, and superficial musculoaponeurotic system. Contemporary rejuvenation has evolved beyond surgical repositioning toward biologically targeted cutaneous optimization. Technology: Energy-based technologies including laser photothermolysis, radiofrequency-mediated dermal thermomodulation, microfocused ultrasound, and emerging microwave and cryobiologic modalities induce controlled tissue injury that activates wound-healing pathways, fibroblast proliferation, and extracellular matrix remodeling. Techniques: Regenerative strategies including microneedling-assisted mechanotransduction, platelet-derived biologics, autologous fat grafting, collagen biostimulators, and extracellular vesicle therapies provide biologically oriented tissue restoration through paracrine signaling and matrix synthesis. Current and Future Development: Artificial intelligence applications in facial phenotyping, treatment planning, and outcome assessment are emerging. Future directions include senescence-targeting therapies and precision-based multimodal protocols. Conclusions and Clinical Relevance: Multimodal treatment sequencing addressing multiple anatomical layers represents the contemporary standard. Integration of device-based technologies with regenerative adjuncts enables biologically informed, individualized facial rejuvenation.
No takes yet. Share an insight, caveat, or question.
Vyas et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: